Seguir
Stephan A. Grupp
Stephan A. Grupp
Professor of Pediatrics, University of Pennsylvania School of Medicine
Dirección de correo verificada de chop.edu
Título
Citado por
Citado por
Año
Chimeric antigen receptor T cells for sustained remissions in leukemia
SL Maude, N Frey, PA Shaw, R Aplenc, DM Barrett, NJ Bunin, A Chew, ...
New England Journal of Medicine 371 (16), 1507-1517, 2014
61622014
Tisagenlecleucel in children and young adults with B-cell lymphoblastic leukemia
SL Maude, TW Laetsch, J Buechner, S Rives, M Boyer, H Bittencourt, ...
New England Journal of Medicine 378 (5), 439-448, 2018
53342018
Chimeric antigen receptor–modified T cells for acute lymphoid leukemia
SA Grupp, M Kalos, D Barrett, R Aplenc, DL Porter, SR Rheingold, ...
New England Journal of Medicine 368 (16), 1509-1518, 2013
43042013
T cells with chimeric antigen receptors have potent antitumor effects and can establish memory in patients with advanced leukemia
M Kalos, BL Levine, DL Porter, S Katz, SA Grupp, A Bagg, CH June
Science translational medicine 3 (95), 95ra73-95ra73, 2011
33032011
Current concepts in the diagnosis and management of cytokine release syndrome
DW Lee, R Gardner, DL Porter, CU Louis, N Ahmed, M Jensen, SA Grupp, ...
Blood, The Journal of the American Society of Hematology 124 (2), 188-195, 2014
30642014
ASTCT consensus grading for cytokine release syndrome and neurologic toxicity associated with immune effector cells
DW Lee, BD Santomasso, FL Locke, A Ghobadi, CJ Turtle, JN Brudno, ...
Biology of blood and marrow transplantation 25 (4), 625-638, 2019
27342019
Anti-GD2 antibody with GM-CSF, interleukin-2, and isotretinoin for neuroblastoma
AL Yu, AL Gilman, MF Ozkaynak, WB London, SG Kreissman, HX Chen, ...
New England Journal of Medicine 363 (14), 1324-1334, 2010
20202010
Chimeric antigen receptor T cells persist and induce sustained remissions in relapsed refractory chronic lymphocytic leukemia
DL Porter, WT Hwang, NV Frey, SF Lacey, PA Shaw, AW Loren, A Bagg, ...
Science translational medicine 7 (303), 303ra139-303ra139, 2015
19732015
CRISPR-Cas9 gene editing for sickle cell disease and β-thalassemia
H Frangoul, D Altshuler, MD Cappellini, YS Chen, J Domm, BK Eustace, ...
New England Journal of Medicine 384 (3), 252-260, 2021
16712021
Chimeric receptors containing CD137 signal transduction domains mediate enhanced survival of T cells and increased antileukemic efficacy in vivo
MC Milone, JD Fish, C Carpenito, RG Carroll, GK Binder, D Teachey, ...
Molecular therapy 17 (8), 1453-1464, 2009
14852009
Dye efflux studies suggest that hematopoietic stem cells expressing low or undetectable levels of CD34 antigen exist in multiple species
MA Goodell, M Rosenzweig, H Kim, DF Marks, MA DeMaria, G Paradis, ...
Nature medicine 3 (12), 1337-1345, 1997
14241997
Convergence of Acquired Mutations and Alternative Splicing of CD19 Enables Resistance to CART-19 Immunotherapy
E Sotillo, DM Barrett, KL Black, A Bagashev, D Oldridge, G Wu, ...
Cancer discovery 5 (12), 1282-1295, 2015
13052015
Antibody-modified T cells: CARs take the front seat for hematologic malignancies
MV Maus, SA Grupp, DL Porter, CH June
Blood, The Journal of the American Society of Hematology 123 (17), 2625-2635, 2014
10902014
Identification of predictive biomarkers for cytokine release syndrome after chimeric antigen receptor T-cell therapy for acute lymphoblastic leukemia
DT Teachey, SF Lacey, PA Shaw, JJ Melenhorst, SL Maude, N Frey, ...
Cancer discovery 6 (6), 664-679, 2016
10872016
‘Off-the-shelf’allogeneic CAR T cells: development and challenges
S Depil, P Duchateau, SA Grupp, G Mufti, L Poirot
Nature reviews Drug discovery 19 (3), 185-199, 2020
10332020
Managing cytokine release syndrome associated with novel T cell-engaging therapies
SL Maude, D Barrett, DT Teachey, SA Grupp
The Cancer Journal 20 (2), 119-122, 2014
8812014
CD19-targeted chimeric antigen receptor T-cell therapy for acute lymphoblastic leukemia
SL Maude, DT Teachey, DL Porter, SA Grupp
Blood, The Journal of the American Society of Hematology 125 (26), 4017-4023, 2015
8772015
Genetic alterations activating kinase and cytokine receptor signaling in high-risk acute lymphoblastic leukemia
KG Roberts, RD Morin, J Zhang, M Hirst, Y Zhao, X Su, SC Chen, ...
Cancer cell 22 (2), 153-166, 2012
8742012
Cytokine release syndrome after blinatumomab treatment related to abnormal macrophage activation and ameliorated with cytokine-directed therapy
DT Teachey, SR Rheingold, SL Maude, G Zugmaier, DM Barrett, AE Seif, ...
Blood, The Journal of the American Society of Hematology 121 (26), 5154-5157, 2013
7062013
Dual CD19 and CD123 targeting prevents antigen-loss relapses after CD19-directed immunotherapies
M Ruella, DM Barrett, SS Kenderian, O Shestova, TJ Hofmann, ...
The Journal of clinical investigation 126 (10), 3814-3826, 2016
6292016
El sistema no puede realizar la operación en estos momentos. Inténtalo de nuevo más tarde.
Artículos 1–20